Ambryon Biosciences

Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors

Pekrun et al. (2019). JCI InsightResearch

Directed-evolution AAV screens had needed four or more selection rounds without barcode tracking; this paper selected barcoded capsid-shuffled libraries on human islets in three rounds, yielding AAV-KP1. KP1 transduced hESC-derived β cells 5- to 10-fold better than AAV-DJ or AAV-LK03.

Author abstract

While gene transfer using recombinant adeno-associated viral (rAAV) vectors has shown success in some clinical trials, there remain many tissues that are not well transduced. Because of the recent success in reprogramming islet-derived cells into functional β cells in animal models, we constructed 2 highly complex barcoded replication competent capsid shuffled libraries and selected for high-transducing variants on primary human islets. We describe the generation of a chimeric AAV capsid (AAV-KP1) that facilitates transduction of primary human islet cells and human embryonic stem cell-derived β cells with up to 10-fold higher efficiency compared with previously studied best-in-class AAV vectors. Remarkably, this chimeric capsid also enabled transduction of both mouse and human hepatocytes at very high levels in a humanized chimeric mouse model, thus providing a versatile vector that has the potential to be used in both preclinical testing and human clinical trials for liver-based diseases and diabetes.

Identifiers & revision